-
While there are a number of reasons why men and their doctors choose a certain initial treatment option for prostate cancer, one of the factors that sometimes comes into play is cost. With many men required to pay a co-pay on any medical care they receive, the allure of ...
-
A Veterans Administration hospital in Philadelphia has been fined an additional $39,000 on top of a previous fine of $227,500 for administering inappropriate doses of radiation to prostate cancer patients.
The hospital's prostate cancer brachytherapy program was recently discovered to have delivered incorrect doses of radiation to patients ...
-
In a newly published study in the British Journal of Cancer, researchers have claimed that they can now determine which of several types of cancer a patient has regardless of age or gender just by analyzing their breath.
The sensor that is being developed makes use of nanoparticles to detect ...
-
US Too International, a non-profit prostate cancer organization, is currently celebrating its 20th year. The group is one of the world's leading promoters of prostate cancer education, advocacy, and awareness.
US Too International was founded in 1990 with a mission to help not just prostate cancer patients, but also their ...
-
Showtime's new television series, "The Big C" drew the largest premiere audience for an original series in the past eight years for the cable channel. While the success of a TV show would normally not be news in the medical world, in this case it is.
That's because "The Big ...
-
A new survey of American Veteran's Administration doctors showed that 64% of urologists and 80% of primary care physicians never prescribed finasteride (or dutasteride) in an attempt to lower the chance of developing prostate cancer. Among primary care physicians, 52% did not know that the drugs could be prescribed ...
-
The Prostate Cancer Foundation is the world's largest financial supporter of prostate cancer research and has a myriad of connections with the corporate and celebrity worlds.
The rapid growth of the Prostate Cancer Foundation into a huge enterprise has been led by its founder Michael Milken who started the charity ...
-
The much-discussed prostate cancer vaccine Progenge, which was approved for sale in the United States in April of this year, has now reached 500 prescriptions.
Dendreon, the producer of Provenge, has said that it has not ramped up to its full manufacturing capacity yet and that there are ...
-
At the end of August, motorcycle riders in over 20 cities across Canada will participate in Motorcycle Ride for Dad, a fundraising event now in its third year.
The event started in Ottawa in 2000 with just 75 riders and now has grown to include participants from across the country.
...
-
In a study which has been previously discussed in this blog, researchers compared surgical outcomes for men with prostate cancer who chose traditional "open" radical prostatectomy versus men who chose laparoscopic prostatectomy.
While the study showed no statistically significant difference in the rates of a number of complications ...
-
While the FDA approved the new prostate cancer vaccine, known as Provenge, in April 2010, the research study that prompted this approval has not yet been fully available.
This week the New England Journal of Medicine published the study in its entirety for the first time.
If you're interested in ...
-
Prostate cancer can be present for months or years without resulting in any symptoms. So how does your doctor detect prostate cancer if there aren't any symptoms.
To detect prostate cancer that has not yet resulted in any symptoms, doctors must use screening tests. The two primary screening tests ...
-
Researchers from South Korea have recently published data that they say suggests a potential link between the length of a man's ring finger and his risk of prostate cancer.
The study found that men with ring fingers which were significantly longer than their index fingers had much higher average ...
-
A new study suggests that taking statins, the popular cholesterol-lowering drugs, may protect against the recurrence of prostate cancer following radical prostatectomy.
The new study, appearing in the July 15 issue of Cancer, found that there was a roughly 30% lower chance of "biochemical recurrence" in men taking statins ...
-
A small study recently presented at the annual meeting of the American Urological Society suggests that it may be possible to detect prostate cancer in men based on the scent of their urine.
Researchers from France reported that they were able to train dogs to differentiate between urine samples ...
-
The American Cancer Society recently published its most recent statistics regarding cancer rates in the United States.
Continuing a trend that began in the early 1990s, the death rate from cancer decreased. There was a roughly 1.3% decrease in overall cancer mortality in 2007 (the most recent year for which ...
-
Major League Baseball hosted an "All-Star Fun Run" with over 9000 participants including "The Biggest Loser" star Jillian Michaels. The event raised over $200,000 for four cancer charities - including the Prostate Cancer Foundation.
The course included a full lap around the warning track of the home field of the ...
-
The FDA recently approved Jevtana, a new chemotherapy drug designed to be used in conjunction with the hormone prednisone to treat men with advanced prostate cancer.
Few treatment options exist for men with advanced prostate cancer and any new addition welcome. The FDA approved Jevtana in an expedited review that ...
-
A new study from Sweden that studied more than 20,000 men has shown that prostate cancer screening saves lives and may cut prostate cancer mortality by almost 50%.
The research, published in the journal Lancet Oncology, does not conclusively end the debate about the overall worth of prostate cancer screening ...
-
Medicare will soon determine whether or not to pay for the the new prostate cancer vaccine Provenge.
The Food and Drug Administration (FDA) has already approved Provenge for sale and distribution in the United States and some Medicare contractors have already begun paying for the treatment.
The final decision ...
